Form: 10-K

Annual report pursuant to Section 13 and 15(d)

March 25, 2021

 

Exhibit 21.1

 

Subsidiaries of the Registrant

 

Jade Therapeutics, Inc. (United States - Delaware)
Panoptes Pharma Ges.m.b.H. (Austria)